Johnson and Johnson 2009 Annual Report Download - page 11

JOHNSON & JOHNSON 2009 ANNUAL REPORT 9




After a breast cancer diagnosis,
Elyssa was able to have her mastectomy and reconstruction in a
single surgery—an option that’s possible because of combined
technologies from Ethicon and its Mentor business unit.
Eclectic. “It’s crucial for me to
look good in my clothes,” says
Elyssa, who wears the colorful
California lifestyle clothes she
sells. What’s more, Elyssa’s
customers expect to see her
running the shop, as she
often does alone. “My business
won’t prosper unless I’m there,”
New technology from Biosense
Webster, Inc. is giving physicians
a detailed three-dimensional
view of the heart so they can treat
dangerous cardiac arrhythmias,
including atrial fibrillation
(AFib). More than  million
people worldwide suer from
AFib, the leading cause of stroke
among people over age .
The ®  System,
launched globally in , takes
physicians on a visual journey
through the heart. The system
maps crucial details of the heart
in color and in real time, helping
physicians to pinpoint
After  years of continued
innovation, DePuy Orthopaedics,
Inc. is the market leader in hip
replacement in many parts of the
world.
“We oer the broadest range
of hip bearings—advanced
materials for the ball and socket
joint of the hip—of any
orthopaedic company,” says
Randy Kilburn, Vice President,
U.S. Marketing, DePuy
Orthopaedics, Inc. “Surgeons
have a significant range of
options from which to choose
to meet the complex clinical
needs of patients.”
DePuy Orthopaedics continues
to pioneer new hip bearings that
provide high stability and low
wear, meeting the needs of the
growing number of active
patients. In August, a U.S. Food
and Drug Administration (FDA)
Advisory Panel recommended
approval of the ®
™ Acetabular Hip
System, the first ceramic-on-metal
abnormalities and fix them
using a procedure known as
ablation.
“The ®  System
represents a significant
advance for patients and physi-
cians,” says Gerd Hindricks,
M.D., Head of the Department
of Electrophysiology at
University of Leipzig Hospital
in Germany. “The accurate
D maps, together with the
ability to visualize the catheter
as it is guided through the
heart chamber, enable me to
eciently perform cardiac
ablation.”
hip bearing to be considered
for approval in the U.S. (While
DePuy Orthopaedics awaits the
FDA’s final decision, the
® ™ System
remains an investigational
device limited by U.S. law to
investigational use only.)
The ® ™
ceramic-on-metal bearing has
been marketed in  countries
outside the U.S. since.
Also in, the company
launched the ™ Hip,
a minimally invasive hip stem
available outside the U.S. only.
The ™ stem, which is
inserted into the femur, is
more
bone-preserving than
traditional
stems. In December,
DePuy Orthopaedics
announced the acquisition
of Finsbury Orthopaedics Ltd.
in the United Kingdom,
a move that makes it the only
company with a large-diameter
one-piece
ceramic-on-ceramic
hip bearing.
she says.
“Elyssa chose an advance in
breast reconstruction that’s
fantastic for a woman who needs
to run her business and keep her
strong self-esteem,” says Dr.
Downey. “It helped her restore
her body and return to her life
quickly.”